DOCSLIB.ORG

Wnt Signaling in Cancer: Not a Binary ON:OFF Switch Dustin J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Wnt Signaling in Cancer: Not a Binary ON:OFF Switch Dustin J Published OnlineFirst August 20, 2019; DOI: 10.1158/0008-5472.CAN-19-1362 Cancer Review Research Wnt Signaling in Cancer: Not a Binary ON:OFF Switch Dustin J. Flanagan1, Elizabeth Vincan2,3, and Toby J. Phesse4,5 Abstract In the March 1 issue of Cancer Research, we identified the polyposis coli (Apc) mutation. Apc is located in the cytoplasm Wnt receptor Fzd7 as an attractive therapeutic target for the downstream of Fzd7 in the Wnt signaling cascade and APC treatment of gastric cancer. In summary, we showed that mutations activate Wnt/b-catenin signaling, therefore, this pharmacological inhibition of Wnt receptors, or genetic dele- result seems counterintuitive. Here, we analyze this result in tion of Fzd7, blocks the initiation and growth of gastric tumors. greater detail in the context of current knowledge of Wnt Inhibiting Fzd receptors, specifically Fzd7, inhibits the growth signaling and discuss the wider implications of this aspect of of gastric cancer cells even in the presence of adenomatous Wnt signaling in other cancers. Regulation of Wnt Signaling Intracellularly including the ligand, receptors, and intracellular transduction and at the Plasma Membrane components (6, 7). In addition to mutations, epigenetic changes are also observed in gastric tumors to Wnt inhibitors such as sFRP The Wnt signaling pathway regulates many cell functions, (binds directly to Wnt ligands) and Dkk1 (binds to and inhibits including proliferation, migration, apoptosis, and differentia- Lrp5/6 receptors), resulting in activation of Wnt signaling at the tion (1). It is essential during embryonic development and also level of the receptor/ligand (1). Indeed, RNF43, an E3 ubiquitin in homeostasis of several adult tissues, including the GI tract (2, 3), ligase that turns over Fzd on the cell surface (8), is mutated in liver, breast, and skin (1), and is deregulated in many cancers, approximately 18% of human gastric tumors, whereas many Wnt including colon, gastric, breast, and liver (4). Wnt ligands are ligands are overexpressed (7). This is around the same frequency secreted glycoproteins that bind to a "U" shaped pocket in the (18%) observed for APC mutations in gastric cancer, approx- dimer of Fzd receptors via a lipid modification of palmitoleic acid imately 37% of which also contain an RNF43 mutation, indicat- to form a receptor complex with co-receptors, including Lrp5/6 ing compound activation of Wnt signaling in the same tumor (7). and Lgr4/5 (1). This complex interacts with components of a This observation that Wnt signaling is regulated intracellularly cytoplasmic "destruction complex" that contains Gsk3, Axin, Ck1, and at the plasma membrane is consistent with our experimental and Apc, to form a large signalosome (1). In the absence of a Wnt data in which we could inhibit the growth of Apc-mutant gastric ligand, newly translated b-catenin proteins are bound and phos- tumors by deleting Fzd7 and prompts a frequently asked question phorylated by the destruction complex. However, in the presence when presenting this work, "how can a cell with mutant Apc of Wnt/Fzd binding, signalosome assembly disrupts this process respond to inhibition of a Fzd receptor upstream?" and b-catenin is free to accumulate, translocate into the nucleus and associate with transcription factors Tcf/Lef to regulate target Heterogenous Wnt signaling regulates distinct cell functions in gene transcription (Fig. 1A; ref. 1). a tumor Nuclear b-catenin, a hallmark of active Wnt signaling (1), is To answer this question, we first need to highlight that Wnt observed in approximately 30% of human gastric tumors (5). signaling is not a binary system whereby the pathway is on or off, Next-generation sequencing has revealed that Wnt signaling is but rather is highly regulated in a compound fashion to provide deregulated in gastric tumors at several points in the pathway, spatial and temporal variation depending on multiple environ- mental factors (9). This was first demonstrated by Thomas Bra- bletz in 1998, who showed heterogenous expression of nuclear b 1Cancer Research UK Beatson Institute, Glasgow, United Kingdom. 2University of -catenin (a surrogate marker of active Wnt signaling) within Melbourne and Victorian Infectious Diseases Reference Laboratory, Doherty human colorectal cancers, despite all tumor cells harboring APC Institute of Infection and Immunity, Melbourne, Australia. 3School of Pharmacy mutation (Fig. 1B; ref. 10). Furthermore, Wnt signaling is pro- and Biomedical Sciences, Curtin University, Perth, Australia. 4European Cancer moted by macrophage-derived TNF-a (11) and H. pylori infection Stem Cell Research Institute, Cardiff University, Cardiff, United Kingdom. can activate the Wnt pathway via Fzd7 (12), highlighting a role for 5Doherty Institute of Infection and Immunity, Melbourne, Australia. the microenvironment for variable Wnt activity in tumors. This Corresponding Authors: Toby J. Phesse, Cell Signalling and Cancer Laboratory, indicates that additional factors can regulate Wnt signal strength European Cancer Stem Cell Research Institute, Cardiff University, Hadyn Ellis even in APC-mutant cells. This can occur because the APC gene is Building, Maindy Road, Cardiff CF24 4HQ, United Kingdom. Phone: 44-0-29- not deleted but truncated and mutant APC is still transcribed and 2068-8495; E-mail: [email protected]; and Elizabeth Vincan, University of Melbourne, Melbourne, Australia. E-mail: [email protected] translated into a protein that is able to partially function in the destruction complex and respond to WNT ligands, albeit at a Cancer Res 2019;XX:XX–XX reduced level (13, 14). Indeed, Wnt3 secretion maintains high doi: 10.1158/0008-5472.CAN-19-1362 Wnt signaling in APC-mutant colon cancer cells (14), whereas Ó2019 American Association for Cancer Research. APC is methylated, and subsequently inhibited further during www.aacrjournals.org OF1 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst August 20, 2019; DOI: 10.1158/0008-5472.CAN-19-1362 Flanagan et al. A Active Wnt signaling Misconceived Wnt signaling Actual Wnt signaling in in Apc-mutant cells Apc-mutant cells Ligand/receptor Fzd inhibitor inhibitors (including sFRP, Wnt RSpo Wnt RSpo Wnt RSpo Fzd Lgr4/5 Fzd LLgr4/5 Fzd Lgr4/5 Dkk) LRP LRP LRP Dvl Dvl Dvl β-Catenin degradation complex Axin Inactive β-catenin Compromised, yet still degradation complex, no role Axin β Axin functional, β-catenin GSK3 for upstream pathway Apc Apcmut degradation complex can be GSK3β GSK3β inhibited by upstream pathway β-cat β-cat β-cat β-cat β-cat β-cat β-cat β-cat β-cat β-cat Nucleus Nucleus Nucleus β-cat β-cat β-cat TCF/LEF TCF/LEF TCF/LEF B β-Catenin immunohistochemistry Colorectal carcinoma Invasive front Tumor center Figure 1. Wnt signaling with mutant Apc. A, The levels of cytoplasmic b-catenin are regulated by the degradation complex that is inhibited when Wnt signaling is active (left). In Apc-mutant cells, it is often misconceived that Apc is completely deleted and therefore the degradation complex is nonfunctional and Wnt signaling cannot be regulated upstream of the degradation complex at the level of the receptor/ligand (illustration faded out; middle). However, mutant Apc is transcribed and translated, resulting in a compromised, yet functional, b-catenin degradation complex that explains how upstream factors, including sFRP, Dkk, and Fzd inhibitors, can still modulate Wnt signal activity (right). B, Immunohistochemistry for b-catenin in a human colorectal carcinoma showing increased nuclear localization, as a surrogate marker of active Wnt, in the invasive front compared with the tumor center. B is reprinted with permission from Brabletz et al. Pathol Res Pract. 1998;194:701–4 (10). tumor progression in colon tumors, highlighting variable cancer and colorectal cancer preferentially select different Wnt activity as a feature of colon tumors (15). This explains why mechanisms of optimal, "just right," levels of Wnt signaling APC-mutant cells are sensitive to Fzd inhibition in our work, but required for tumor growth and progression. The "just right" what is the function of this variable Wnt signal? model of Wnt signaling proposes APC mutations are selected for Approximately 37% of APC-mutant gastric tumors also contain sub-maximal levels of Wnt signaling to provide a Wnt signal that RNF43 mutations, indicating compound activation of Wnt sig- is sufficient to transform cells, but not excessive and cytotox- naling in the same tumor (3). However, only 5.5% of colon ic (16). Experimental evidence from in vivo data helped confirm 1322T/þ tumors have APC and RNF43 mutations, suggesting that gastric these models. For instance, the Apc mouse model retains a OF2 Cancer Res; 2019 Cancer Research Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst August 20, 2019; DOI: 10.1158/0008-5472.CAN-19-1362 Wnt Signaling in Apc-Mutant Cells Liver Stomach Lung CRC Intracellular = 46.8% Intracellular = 39.1% Intracellular = 21.8% Intracellular = 82.5% Receptor = 48.7% Receptor = 57.0% Receptor = 59.1% Receptor = 38.0% GBM Breast Melanoma Prostate Intracellular = 8.4% Intracellular = 13.8% Intracellular = 26.5% Intracellular = 22.7% Receptor = 19.0% Receptor = 43.6% Receptor = 58.9% Receptor = 40.9% Intracellular Amplification Deletion Multiple alteration Head & Neck Ovarian Bladder Mutation Intracellular = 31.38% Intracellular = 30.1% Intracellular
Load more

Recommended publications
  • WNT3 Is a Biomarker Capable of Predicting the Definitive Endoderm Differentiation Potential of Hescs
    WNT3 Is a Biomarker Capable of Predicting the Definitive Endoderm Differentiation Potential of hESCs The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Jiang, Wei, Donghui Zhang, Nenad Bursac, and Yi Zhang. 2013. “WNT3 Is a Biomarker Capable of Predicting the Definitive Endoderm Differentiation Potential of hESCs.” Stem Cell Reports 1 (1): 46-52. doi:10.1016/j.stemcr.2013.03.003. http:// dx.doi.org/10.1016/j.stemcr.2013.03.003. Published Version doi:10.1016/j.stemcr.2013.03.003 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11877118 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Stem Cell Reports Report WNT3 Is a Biomarker Capable of Predicting the Definitive Endoderm Differentiation Potential of hESCs Wei Jiang,1,2,3,* Donghui Zhang,6 Nenad Bursac,6 and Yi Zhang1,2,3,4,5,* 1Howard Hughes Medical Institute 2Program in Cellular and Molecular Medicine 3Division of Hematology/Oncology, Department of Pediatrics, Boston Children’s Hospital 4Department of Genetics Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA 5Harvard Stem Cell Institute, WAB-149G, 200 Longwood Avenue, Boston, MA 02115, USA 6Department of Biomedical Engineering, Duke University, 3000 Science Drive, Hudson Hall 136, Durham, NC 27708, USA *Correspondence: [email protected] (W.J.), [email protected] (Y.Z.) http://dx.doi.org/10.1016/j.stemcr.2013.03.003 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • WNT11-Conditioned Medium Promotes Angiogenesis Through the Activation of Non-Canonical WNT-PKC-JNK Signaling Pathway
    G C A T T A C G G C A T genes Article WNT11-Conditioned Medium Promotes Angiogenesis through the Activation of Non-Canonical WNT-PKC-JNK Signaling Pathway § Jingcai Wang y, Min Gong z, Shi Zuo , Jie Xu, Chris Paul, Hongxia Li k, Min Liu, Yi-Gang Wang, Muhammad Ashraf ¶ and Meifeng Xu * Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA; [email protected] (J.W.); [email protected] (M.G.); [email protected] (S.Z.); [email protected] (J.X.); [email protected] (C.P.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (Y.-G.W.); [email protected] (M.A.) * Correspondence: [email protected] Current address: Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, y Columbus, OH 43205, USA. Current Address: Department of Neonatology, Children’s Hospital of Soochow University, z Suzhou 215025, Jiangsu, China. § Current Address: Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang 550025, Guizhou, China. Current Address: Department of Cardiology, The First Affiliated Hospital of Soochow University, k Suzhou 215006, Jiangsu, China. ¶ Current Address: Department of Medicine, Cardiology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Received: 10 August 2020; Accepted: 26 October 2020; Published: 29 October 2020 Abstract: Background: We demonstrated that the transduction of Wnt11 into mesenchymal stem cells (MSCs) (MSCWnt11) promotes these cells differentiation into cardiac phenotypes. In the present study, we investigated the paracrine effects of MSCWnt11 on cardiac function and angiogenesis.
    [Show full text]
  • Extrinsic Regulators of Mrna Translation in Developing Brain: Story of Wnts
    cells Article Extrinsic Regulators of mRNA Translation in Developing Brain: Story of WNTs Yongkyu Park * , Midori Lofton , Diana Li and Mladen-Roko Rasin * Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ 08854, USA; [email protected] (M.L.); [email protected] (D.L.) * Correspondence: [email protected] (Y.P.); [email protected] (M.-R.R.) Abstract: Extrinsic molecules such as morphogens can regulate timed mRNA translation events in developing neurons. In particular, Wingless-type MMTV integration site family, member 3 (Wnt3), was shown to regulate the translation of Foxp2 mRNA encoding a Forkhead transcription factor P2 in the neocortex. However, the Wnt receptor that possibly mediates these translation events remains unknown. Here, we report Frizzled member 7 (Fzd7) as the Wnt3 receptor that lays downstream in Wnt3-regulated mRNA translation. Fzd7 proteins co-localize with Wnt3 ligands in developing neo- cortices. In addition, the Fzd7 proteins overlap in layer-specific neuronal subpopulations expressing different transcription factors, Foxp1 and Foxp2. When Fzd7 was silenced, we found decreased Foxp2 protein expression and increased Foxp1 protein expression, respectively. The Fzd7 silencing also dis- rupted the migration of neocortical glutamatergic neurons. In contrast, Fzd7 overexpression reversed the pattern of migratory defects and Foxp protein expression that we found in the Fzd7 silencing. We further discovered that Fzd7 is required for Wnt3-induced Foxp2 mRNA translation. Surprisingly, we also determined that the Fzd7 suppression of Foxp1 protein expression is not Wnt3 dependent. In conclusion, it is exhibited that the interaction between Wnt3 and Fzd7 regulates neuronal identity and the Fzd7 receptor functions as a downstream factor in ligand Wnt3 signaling for mRNA translation.
    [Show full text]
  • Wnt Signaling in Cancer: Not a Binary ON:OFF Switch
    Author Manuscript Published OnlineFirst on August 20, 2019; DOI: 10.1158/0008-5472.CAN-19-1362 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Wnt signaling in cancer: not a binary ON:OFF switch Dustin J. Flanagan1, Elizabeth Vincan2,# and Toby J. Phesse3,*. 1 Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK 2 University of Melbourne & Victorian Infectious Diseases Reference Laboratory, Doherty Institute of Infection and Immunity, Melbourne, VIC 3010, Australia and School of Pharmacy and Biomedical Sciences, Curtin University, Perth, Australia. 3 European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK and Doherty Institute of Infection and Immunity, Melbourne, VIC 3010, Australia. *Corresponding author: Toby J. Phesse. Mailing address; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK. Email; [email protected]. Phone number: +44 (0)29 2068 8495. # Corresponding author: Elizabeth Vincan. Mailing address; University of Melbourne & Victorian Infectious Diseases Reference Laboratory, Doherty Institute of Infection and Immunity, Melbourne, VIC 3010, Australia. Email: [email protected], Phone number: +61 3 9035 3555. The authors declare no potential conflicts of interest. Running Title: Wnt signaling in Apc mutant cells 1 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 20, 2019; DOI: 10.1158/0008-5472.CAN-19-1362 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract In the March 1st issue of Cancer Research, we identified the Wnt receptor Fzd7 as an attractive therapeutic target for the treatment of gastric cancer.
    [Show full text]
  • Towards an Integrated View of Wnt Signaling in Development Renée Van Amerongen and Roel Nusse*
    HYPOTHESIS 3205 Development 136, 3205-3214 (2009) doi:10.1242/dev.033910 Towards an integrated view of Wnt signaling in development Renée van Amerongen and Roel Nusse* Wnt signaling is crucial for embryonic development in all animal Notably, components at virtually every level of the Wnt signal species studied to date. The interaction between Wnt proteins transduction cascade have been shown to affect both β-catenin- and cell surface receptors can result in a variety of intracellular dependent and -independent responses, depending on the cellular responses. A key remaining question is how these specific context. As we discuss below, this holds true for the Wnt proteins responses take shape in the context of a complex, multicellular themselves, as well as for their receptors and some intracellular organism. Recent studies suggest that we have to revise some of messengers. Rather than concluding that these proteins are shared our most basic ideas about Wnt signal transduction. Rather than between pathways, we instead propose that it is the total net thinking about Wnt signaling in terms of distinct, linear, cellular balance of signals that ultimately determines the response of the signaling pathways, we propose a novel view that considers the receiving cell. In the context of an intact and developing integration of multiple, often simultaneous, inputs at the level organism, cells receive multiple, dynamic, often simultaneous and of both Wnt-receptor binding and the downstream, sometimes even conflicting inputs, all of which are integrated to intracellular response. elicit the appropriate cell behavior in response. As such, the different signaling pathways might thus be more intimately Introduction intertwined than previously envisioned.
    [Show full text]
  • Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular
    ANTICANCER RESEARCH 36 : 4545-4552 (2016) doi:10.21873/anticanres.11002 Altered Expression of PRKX , WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma NATALIA GURGEL DO CARMO 1,2 , LUIS HENRIQUE TOSHIHIRO SAKAMOTO 3, ROBERT POGUE 1, CINTIA DO COUTO MASCARENHAS 1, SIMONE KARST PASSOS 4, MARIA SUELI SOARES FELIPE 1,2 and ROSÂNGELA VIEIRA DE ANDRADE 1 1Program of Genomic Sciences and Biotechnology, Catholic University of Brasília, Brasília, DF, Brazil; 2Program of Molecular Pathology, University of Brasília, Brasília, DF, Brazil; 3Domingos A. Boldrini Center for Hematological Investigation, Campinas, SP, Brazil; 4Dermatology Service, Asa Norte Regional Hospital, Brasília, DF, Brazil Abstract. Background/Aim: Nodular and superficial are the differences in their biological behavior, such as tumor most common subtypes of basal cell carcinoma (BCC). growth pattern, potential for recurrence and metastasis, Signaling pathways such as Hedgehog (HH) and Wingless histological pattern and genetic factors. In addition, it is (WNT) signaling are associated with BCC phenotypic important to consider extrinsic factors, such as site of origin, variation. The aim of the study was to evaluate of the therapeutic choice and immunological state of the person expression profiles of 84 genes related to the WNT and HH with the tumor (3). Nodular BCC is the most common signaling pathways in patients with nodular and superficial biopsied subtype; it usually manifests as a single lesion and BCC. Materials and Methods: A total of 58 BCCs and 13 mostly affects head and neck areas (8). Histologically, the samples of normal skin were evaluated by quantitative real- tumor is a well-defined structure with precise contours; it time polymerase chain reaction (qPCR) to detect the gene- presents basaloid cells of nodular mass separated from the expression profile.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • WNT3 FISH Probe
    WNT3 FISH Probe expression suggest that this gene may play a key role in some cases of human breast, rectal, lung, and gastric Catalog Number: FA0393 cancer through activation of the WNT-beta-catenin-TCF signaling pathway. This gene is clustered with WNT15, Regulatory Status: For research use only (RUO) another family member, in the chromosome 17q21 region. [provided by RefSeq] Product Description: Made to order FISH probes for identification of gene amplification using Fluorescent In Situ Hybridization Technique. (Technology) Source: Genomic DNA Origin: Human Notice: We strongly recommend the customer to use FFPE FISH PreTreatment Kit 1 (Catalog #: KA2375 or KA2691) for the pretreatment of Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections. Applications: FISH-Ce (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Supplied Product: DAPI Counterstain (1500 ng/mL ) 250 uL Storage Instruction: Store at 4°C in the dark. Entrez GeneID: 7473 Gene Symbol: WNT3 Gene Alias: INT4, MGC131950, MGC138321, MGC138323 Gene Summary: The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to human WNT3A protein, another WNT gene product. The mouse studies show the requirement of Wnt3 in primary axis formation in the mouse.
    [Show full text]
  • WNT3 Hypopethylation Counteracts Low Activity of the Wnt Signaling Pathway in the Placenta of Preeclampsia
    WNT3 Hypopethylation Counteracts low Activity of the Wnt Signaling Pathway in the Placenta of Preeclampsia Linlin Zhang ( [email protected] ) Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital https://orcid.org/0000-0003-0204-7972 Min Sang Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Ying Li Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Yingying Li Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Lijun Yang Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Wenli Shi Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Yangyang Yuan Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Bo Yang Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Peifeng Yang Zhengzhou University Third Hospital and Henan Province Women and Children's Hospital Research Article Keywords: Preeclampsia, Placentas, WNT3 gene, Hypopethylation, β-Catenin Posted Date: June 17th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-609900/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/26 Abstract Preeclampsia is a hypertensive disorder of pregnancy. Many studies have shown that epigenetic mechanisms may play a role in preeclampsia. Moreover, our previous study indicated that the differentially methylated genes in preeclampsia were enriched in the Wnt/β-catenin signaling pathway. This study aimed to identify differentially methylated Wnt/β-catenin signaling pathway genes in the preeclamptic placenta and to study the roles of these genes in trophoblast cells in vitro.
    [Show full text]
  • Reciprocal Regulation of Wnt and Gpr177/Mouse Wntless Is Required for Embryonic Axis Formation
    Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation Jiang Fu1, Ming Jiang1, Anthony J. Mirando1, Hsiao-Man Ivy Yu, and Wei Hsu2 Department of Biomedical Genetics, Center for Oral Biology, James P Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Box 611, Rochester, NY 14642 Edited by Kathryn V. Anderson, Sloan-Kettering Institute, New York, NY, and approved September 16, 2009 (received for review May 6, 2009) Members of the Wnt family are secreted glycoproteins that trigger Gpr177, the mouse orthologue of Drosophila Wls, required for cellular signals essential for proper development of organisms. Cel- embryogenesis. Disruption of Gpr177 disturbs axial patterning, a lular signaling induced by Wnt proteins is involved in diverse devel- phenotype resembling the loss of Wnt3. This disruption not only opmental processes and human diseases. Previous studies have affects Wnt production, but also interferes with Wnt signaling. As generated an enormous wealth of knowledge on the events in a Wnt transcriptional target, Gpr177 is elevated to promote Wnt signal-receiving cells. However, relatively little is known about the production in a positive feedback loop. Our results indicate that a making of Wnt in signal-producing cells. Here, we describe that reciprocal regulation of Wnt and Gpr177 is essential for the Gpr177, the mouse orthologue of Drosophila Wls, is expressed during establishment of the mammalian A-P axis. formation of embryonic axes. Embryos with deficient Gpr177 exhibit defects in establishment of the body axis, a phenotype highly remi- Results niscent to the loss of Wnt3. Although many different mammalian Wnt Gpr177 Is Essential for Mouse Embryogenesis.
    [Show full text]
  • Wnt2b, Wnt3, and R-Spondin-1 Promote -Catenin Signaling in The
    ew Vol 3 | Issue 1| Pages 31-39 Insights of Stem Cell Research and Therapy Original Article DOI: 10.36959/498/610 Wnt2b, Wnt3, and R-Spondin-1 Promote β-Catenin Signaling in the Small Intestine during Infancy Zenab M Dudhwala1,2*, Rino P Donato1,2, Wendy J Uylaki1,2, Paul D Hammond3,4, Check for Gordon S Howarth5,6 and Adrian G Cummins1,2,3 updates 1Department of Gastroenterology and Hepatology, Basil Hetzel Institute for Translational Health Research Woodville South, Australia 2The Queen Elizabeth Hospital, Woodville South, Australia 3Discipline of Medicine, School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia 4School of Pediatrics, Faculty of Health Sciences, University of Adelaide, North Adelaide, Australia 5Women’s and Children’s Hospital, North Adelaide, Australia 6School of Animal and Veterinary Sciences, University of Adelaide, Rose worthy, Australia Abstract Background and aim: The Wnt-β-catenin signaling pathway is active in the stem cell region of intestinal crypts during postnatal growth of the small intestine. This functions to construct and maintain an intestinal stem cell niche in the base of crypts and to protect stem cells from apoptosis. The aim of this study was to identify which Wnt agonists are present to mediate this activity. Methods: RNA was extracted from rats at day 14 infant (n = 4) and day 72 (n = 4) of life and analysed by real time PCR array to identify which Wnts were up regulated during infancy with selected Wnts localized by laser capture microscopy and PCR. Subsequently, Wnts were assessed in intestinal homogenates by individual Wnt real time quantitative PCR using different primer sets from litters (n = 6) at 7, 14, 21, 28, 35 and 72 days of life in rats.
    [Show full text]
  • WNT3 (Human) Recombinant Protein (P01)
    WNT3 (Human) Recombinant Gene Alias: INT4, MGC131950, MGC138321, Protein (P01) MGC138323 Gene Summary: The WNT gene family consists of Catalog Number: H00007473-P01 structurally related genes which encode secreted Regulation Status: For research use only (RUO) signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, Product Description: Human WNT3 full-length ORF ( including regulation of cell fate and patterning during NP_110380.1, 1 a.a. - 355 a.a.) recombinant protein with embryogenesis. This gene is a member of the WNT GST-tag at N-terminal. gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to Sequence: human WNT3A protein, another WNT gene product. The MEPHLLGLLLGLLLGGTRVLAGYPIWWSLALGQQYTS mouse studies show the requirement of Wnt3 in primary LGSQPLLCGSIPGLVPKQLRFCRNYIEIMPSVAEGVKL axis formation in the mouse. Studies of the gene GIQECQHQFRGRRWNCTTIDDSLAIFGPVLDKATRES expression suggest that this gene may play a key role in AFVHAIASAGVAFAVTRSCAEGTSTICGCDSHHKGPP some cases of human breast, rectal, lung, and gastric GEGWKWGGCSEDADFGVLVSREFADARENRPDARS cancer through activation of the WNT-beta-catenin-TCF AMNKHNNEAGRTTILDHMHLKCKCHGLSGSCEVKTC signaling pathway. This gene is clustered with WNT15, WWAQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWV another family member, in the chromosome 17q21 ETLRAKYSLFKPPTERDLVYYENSPNFCEPNPETGSF region. [provided by RefSeq] GTRDRTCNVTSHGIDGCDLLCCGRGHNTRTEKRKEK CHCIFHWCCYVSCQECIRIYDVHTCK References: 1. Thalamic WNT3 Secretion Spatiotemporally Host: Wheat Germ (in vitro) Regulates the Neocortical Ribosome Signature and mRNA Translation to Specify Neocortical Cell Subtypes. Theoretical MW (kDa): 66 Kraushar ML, Viljetic B, Wijeratne HR, Thompson K, Jiao X, Pike JW, Medvedeva V, Groszer M, Kiledjian M, Applications: AP, Array, ELISA, WB-Re Hart RP, Rasin MR. J Neurosci. 2015 Aug (See our web site product page for detailed applications 5;35(31):10911-26.
    [Show full text]